| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.5M | — |
| R&D Expense | $91.2M | -30.9% |
| SG&A Expense | $37.4M | -9.6% |
| Operating Income | -$162.4M | +6.2% |
| Interest Expense | $3.8M | +166.0% |
| Income Tax | $0 | — |
| Net Income | -$166.0M | +4.9% |
| EPS (Basic) | -$3.78 | +18.5% |
| EPS (Diluted) | -$3.78 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $87.9M | -41.1% |
| Current Assets | $96.4M | -39.6% |
| Total Assets | $126.3M | -41.0% |
| Current Liabilities | $62.8M | +21.3% |
| Long-term Debt | $38.0M | +2.1% |
| Total Liabilities | $125.3M | +5.7% |
| Stockholders' Equity | $949K | -99.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$88.4M | +24.5% |
| Capital Expenditures | $20.6M | +34.7% |
| Investing Cash Flow | -$24.9M | -15.7% |
| Financing Cash Flow | $52.1M | +33.3% |
| Free Cash Flow | -$109.0M | +17.6% |
| +18.5% |